Skip to content
10-Q

Quarterly Report

2seventy bio, Inc.

0001860782-25-000037

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 5, 2025 53.23M sh
Shares Diluted Q1 2025 · Mar 31, 2025 53.43M sh
Shares Diluted Q1 2025 · Mar 31, 2024 52.07M sh
Capex Q1 2025 · Mar 31, 2025 $0
Capex Q1 2025 · Mar 31, 2024 $612K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$10.97M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$41.88M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $92.36M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $71.24M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $56.79M
Stockholders Equity Q1 2025 · Mar 31, 2025 $213.96M
Stockholders Equity Q1 2025 · Dec 31, 2024 $210.81M
Stockholders Equity Q1 2025 · Mar 31, 2024 $207.44M
Stockholders Equity Q1 2025 · Dec 31, 2023 $255.3M
Current Liabilities Q1 2025 · Mar 31, 2025 $41.4M
Current Liabilities Q1 2025 · Dec 31, 2024 $40.09M
Total Liabilities Q1 2025 · Mar 31, 2025 $266.04M
Total Liabilities Q1 2025 · Dec 31, 2024 $268.7M
Current Assets Q1 2025 · Mar 31, 2025 $198.58M
Current Assets Q1 2025 · Dec 31, 2024 $187.26M
Total Assets Q1 2025 · Mar 31, 2025 $480.01M
Total Assets Q1 2025 · Dec 31, 2024 $479.51M
Eps Diluted Q1 2025 · Mar 31, 2025 $0.01
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.01
Eps Basic Q1 2025 · Mar 31, 2025 $0.01
Eps Basic Q1 2025 · Mar 31, 2024 −$1.01
Sga Expense Q1 2025 · Mar 31, 2025 $14.85M
Sga Expense Q1 2025 · Mar 31, 2024 $12.66M
Rd Expense Q1 2025 · Mar 31, 2025 $5.4M
Rd Expense Q1 2025 · Mar 31, 2024 $43.93M
Net Income Q1 2025 · Mar 31, 2025 $482K
Net Income Q1 2025 · Mar 31, 2024 −$52.67M
Operating Income Q1 2025 · Mar 31, 2025 −$2.52M
Operating Income Q1 2025 · Mar 31, 2024 −$51.15M
Revenue Q1 2025 · Mar 31, 2025 $22.94M
Revenue Q1 2025 · Mar 31, 2024 $12.44M